A new study from researchers at Wake Forest University School of Medicine shows that only 3.5 years of intensive blood ...

Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild ...

During the years of follow-up, 248 of those who had undergone intensive blood pressure treatment were determined to have probable dementia or mild cognitive impairment, compared with 293 ...

Researchers specifically found that participants in the intensive treatment group had a lower rate of mild cognitive impairment and a lower combined rate of mild cognitive impairment or probable ...

Rates of both MCI and composite of MCI or probable dementia lower with intensive treatment in extended follow-up study.

A new study shows that only 3½ years of intensive blood pressure control continues to significantly reduce the risk of mild ...

mild cognitive impairment or probable dementia. "We found that the intensive treatment group had a sustained lower incidence of developing cognitive impairment compared to those in the standard ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...

Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.